Literature DB >> 2161051

Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.

J A Van Strijp1, L A Miltenburg, M E van der Tol, K P Van Kessel, A C Fluit, J Verhoef.   

Abstract

The degradation of herpes simplex virus particles after uptake by phagocytes was studied, but, since lysis of the phagocyte also resulted in damage to the viral envelope, measurement of viral infectivity as a criterion of viral degradation after phagocytosis was not possible. Therefore we focused on later events in viral destruction, namely the degradation of macromolecules. We have demonstrated that polymorphonuclear leukocytes (PMN) and monocytes (MN) can rapidly degrade the membrane proteins of the phagocytosed herpes-virus virions. PMN and MN from a patient with chronic granulomatous disease showed a similar rate of degradation compared to PMN and MN from healthy donors, which excludes an important role for toxic oxygen species in viral protein degradation. Experiments using toxic oxygen species-generating systems supported this observation. In contrast to PMN, MN are also effective in the digestion of viral DNA. We conclude that PMN and MN are able to neutralize large amounts of phagocytosed HSV, so their role in antiviral defence has again been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161051     DOI: 10.1099/0022-1317-71-5-1205

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Authors:  Kuan Rong Chan; Summer Li-Xin Zhang; Hwee Cheng Tan; Ying Kai Chan; Angelia Chow; Angeline Pei Chiew Lim; Subhash G Vasudevan; Brendon J Hanson; Eng Eong Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

3.  Highly attenuated poxviruses induce functional priming of neutrophils in vitro.

Authors:  R Förster; G Wolf; A Mayr
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Degradation of Japanese encephalitis virus by neutrophils.

Authors:  S Srivastava; N Khanna; S K Saxena; A Singh; A Mathur; T N Dhole
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

5.  Stimulation of neutrophil respiratory burst and degranulation by Japanese encephalitis virus-induced macrophage derived factor.

Authors:  N Khanna; S Srivastav; A Mathur; U C Chaturvedi
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

6.  Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of HSV-1 in BALB/c mice.

Authors:  Mei Zheng; Mark A Fields; Yi Liu; Heather Cathcart; Elizabeth Richter; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

7.  NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2.

Authors:  Sara Sinha; Natalia Cheshenko; Robert I Lehrer; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 8.  Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.

Authors:  Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Barbara Owczarek; Ryszard Międzybrodzki; Marzanna Łusiak-Szelachowska; Norbert Łodej; Andrzej Górski
Journal:  Viruses       Date:  2017-06-14       Impact factor: 5.048

Review 9.  Complement Evasion Strategies of Viruses: An Overview.

Authors:  Palak Agrawal; Renuka Nawadkar; Hina Ojha; Jitendra Kumar; Arvind Sahu
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

Review 10.  Viral mimicry of the complement system.

Authors:  John Bernet; Jayati Mullick; Akhilesh K Singh; Arvind Sahu
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.